Seres Therapeutics (MCRB) Non Operating Interest Expenses (2020 - 2024)
Seres Therapeutics' Non Operating Interest Expenses came in at $618,000 for Q1 2024, down 68.3% from $1.95 million a year earlier.
Powered by 
Analysis
Seres Therapeutics (MCRB) Non Operating Interest Expenses (2020 - 2024) Analysis & Trends
For FY2023, Seres Therapeutics' Non Operating Interest Expenses was $2.47 million, down 59.0% from FY2022.
- Non Operating Interest Expenses carries a four-year compound annual growth rate of 48.9% (FY2019 to FY2023).
- Going back by year, Non Operating Interest Expenses was $6.02 million in FY2022 (+106.9%), $2.91 million in FY2021 (-0.5%), $2.92 million in FY2020 (+482.5%) and $502,000 in FY2019.
- The Q1 2024 figure represents the lowest quarterly Non Operating Interest Expenses in data going back to Q1 2020.
- Year-over-year, Non Operating Interest Expenses increased in five of the last six quarters, with growth averaging 91.6%.
- The fastest year-over-year change in Non Operating Interest Expenses over five years came in Q4 2022 (growth of 154.7%), and the weakest in Q1 2024 (a decline of 68.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | - |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 462.00 Mn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 435.00 Mn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | - |
| 10 | Seres Therapeutics | 20.93 Mn | -117.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 618,000.00 |
| Jun 30, 2023 | 3.19 Mn |
| Mar 31, 2023 | 1.95 Mn |
| Dec 31, 2022 | 1.88 Mn |
| Sep 30, 2022 | 1.73 Mn |
| Jun 30, 2022 | 1.50 Mn |
| Mar 31, 2022 | 912,000.00 |
| Dec 31, 2021 | 738,000.00 |
| Sep 30, 2021 | 744,000.00 |
| Jun 30, 2021 | 732,000.00 |
| Mar 31, 2021 | 696,000.00 |
| Dec 31, 2020 | 759,000.00 |
| Sep 30, 2020 | 730,000.00 |
| Jun 30, 2020 | 719,000.00 |
| Mar 31, 2020 | 716,000.00 |
API Access
Seres Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=MCRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "MCRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=MCRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();